Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caplice

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Microbiome|March 14, 2017
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E<sup>-/-</sup> micePaul M Ryan, Lis E E London, Trent C Bjorndahl, et al.
Circulation. Cardiovascular Interventions|June 30, 2011
Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarctionJohn F O'Sullivan, Anne-Laure Leblond, Geraldine Kelly, et al.
JACC. Basic to Translational Science|February 5, 2025
Targeting the Gut-Heart Axis Improves Cardiac Remodeling in a Clinical Scale Model of Cardiometabolic SyndromeFlorence M Herisson, Gaston L Cluzel, Maria Antonia Llopis-Grimalt, et al.
Biomaterials|August 16, 2015
A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammationMohammed T Ali, Kenneth Martin, Arun H S Kumar, et al.
The Journal of Nutrition|October 17, 2014
Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient miceLis E E London, Arun H S Kumar, Rebecca Wall, et al.
Stem Cells and Development|June 20, 2008
Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1Brendan Doyle, Paul Sorajja, Brian Hynes, et al.
BMC Microbiology|February 10, 2019
Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbePaul M Ryan, Ellen H Stolte, Lis E E London, et al.
Biomaterials|August 7, 2014
Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusionArun H S Kumar, Kenneth Martin, Brendan Doyle, et al.
Stem Cells (Dayton, Ohio)|May 14, 2015
Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin TherapyBirgitta M Gleeson, Kenneth Martin, Mohammed T Ali, et al.
Biomedical Physics & Engineering Express|November 12, 2021
Development of a dosimeter prototype with machine learning based 3-D dose reconstruction capabilitiesG M Finneman, O H Eichhorn, N R Meskell, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Microbiome|March 14, 2017
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E<sup>-/-</sup> micePaul M Ryan, Lis E E London, Trent C Bjorndahl, et al.
Circulation. Cardiovascular Interventions|June 30, 2011
Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarctionJohn F O'Sullivan, Anne-Laure Leblond, Geraldine Kelly, et al.
JACC. Basic to Translational Science|February 5, 2025
Targeting the Gut-Heart Axis Improves Cardiac Remodeling in a Clinical Scale Model of Cardiometabolic SyndromeFlorence M Herisson, Gaston L Cluzel, Maria Antonia Llopis-Grimalt, et al.
Biomaterials|August 16, 2015
A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammationMohammed T Ali, Kenneth Martin, Arun H S Kumar, et al.
The Journal of Nutrition|October 17, 2014
Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient miceLis E E London, Arun H S Kumar, Rebecca Wall, et al.
Stem Cells and Development|June 20, 2008
Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1Brendan Doyle, Paul Sorajja, Brian Hynes, et al.
BMC Microbiology|February 10, 2019
Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbePaul M Ryan, Ellen H Stolte, Lis E E London, et al.
Biomaterials|August 7, 2014
Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusionArun H S Kumar, Kenneth Martin, Brendan Doyle, et al.
Stem Cells (Dayton, Ohio)|May 14, 2015
Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin TherapyBirgitta M Gleeson, Kenneth Martin, Mohammed T Ali, et al.
Biomedical Physics & Engineering Express|November 12, 2021
Development of a dosimeter prototype with machine learning based 3-D dose reconstruction capabilitiesG M Finneman, O H Eichhorn, N R Meskell, et al.
Pageof 15